Origen de la red de primer grado Robert Orr.
Entidad | Tipo de entidad | Industria | |
---|---|---|---|
Hallux, Inc.
Hallux, Inc. Pharmaceuticals: MajorHealth Technology Hallux, Inc. provides pharmaceutical services. It develops a new terbinafine dosage form and subungual route of administration for the treatment of onychomycosis. The company was founded by Mark T. Taylor, Jay Edward Birnbaum, Hendrik Arend Kroon and Robert Orr in 2012 and is headquartered in Laguna Hills, CA.
6
| Holding Company | Pharmaceuticals: Major | 6 |
Gráfico Empresas conectadas de segundo grado
Relaciones con varias empresas
Empresas conectadas a Robert Orr a través de su red personal
Empresa | Sector | Personas relacionadas | Puesto principal |
---|---|---|---|
HERON THERAPEUTICS, INC. | Biotechnology | Corporate Officer/Principal | |
Wyeth Holdings LLC
Wyeth Holdings LLC Chemicals: AgriculturalProcess Industries Wyeth Holdings LLC manufactures and distributes chemicals. The firm's chemical contains phosphate rock, calcium, lime, carbide and nitrogen which are used in fertilizers. The company was founded by Frank Washburn in 1907 and is headquartered in Wayne, NJ. | Chemicals: Agricultural | Corporate Officer/Principal | |
Bausch Health Americas, Inc.
Bausch Health Americas, Inc. Pharmaceuticals: MajorHealth Technology Bausch Health Americas, Inc. manufactures and distributes pharmaceutical products. The company was founded on November 29, 2011 and is headquartered in Bridgewater, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal | |
SALIX PHARMACEUTICALS, LTD. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Obagi Medical Products, Inc.
Obagi Medical Products, Inc. Pharmaceuticals: MajorHealth Technology Obagi Medical Products, Inc. develops, markets, and sells proprietary topical aesthetic and therapeutic prescription-strength skin care systems. It designed to help minimize the appearance of premature skin aging, skin damage, hyperpigmentation, acne, and sun damage and are primarily available through dermatologists, plastic surgeons, medical spas, and other skin care professionals. The company was founded in 1988 and is headquartered in Irvine, CA. | Pharmaceuticals: Major | Investor Relations Contact | |
Metabasis Therapeutics, Inc.
Metabasis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Metabasis Therapeutics, Inc. engages in discovery, development and commercialization of novel drugs for metabolic diseases using the proprietary technology and the knowledge of processes and pathways within the liver that are useful for liver-selective drug targeting and treatment of metabolic diseases. Metabasis was incorporated in April 1997 and is headquartered in La Jolla, CA. | Pharmaceuticals: Major | General Counsel | |
SONOMA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
KYTHERA BIOPHARMACEUTICALS INC | Pharmaceuticals: Major | Founder | |
Thesan Pharmaceuticals, Inc.
Thesan Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Thesan Pharmaceuticals, Inc. provides novel therapeutics for disorders of the skin. The company focuses on the discovery and development of new chemical entities that provide improved treatment options to patients. Thesan Pharmaceuticals was founded in 2011 by Edward P. Monaghan and is headquartered in Carlsbad, CA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
NOVARTIS AG | Pharmaceuticals: Major | Corporate Officer/Principal | |
ROTH Capital Partners LLC
ROTH Capital Partners LLC Investment Banks/BrokersFinance ROTH Capital Partners LLC is a broker/dealer headquartered in Newport Beach, California. The firm was founded in 2001 and is a subsidiary of CR Financial Holdings, Inc. They offer institutional sales and trading services. Their broad institutional coverage includes investors in North America, Canada, UK, Europe and other international territories. | Investment Banks/Brokers | Analyst-Equity | |
Amherst College | College/University | Undergraduate Degree | |
Creighton University | College/University | Doctorate Degree | |
Trinity College (Connecticut) | College/University | Undergraduate Degree | |
Tulane University (Louisiana) | College/University | Undergraduate Degree | |
University of Wisconsin | College/University | Doctorate Degree | |
Novartis Pharmaceuticals Corp.
Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Otsuka America Pharmaceutical, Inc.
Otsuka America Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Otsuka America Pharmaceutical, Inc. manufactures and supplies pharmaceutical products. It develops drugs for neuroscience, cardiovascular, and gastrointestinal treatments. The company was founded in 1989 and is headquartered in Rockville, MD. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Excaliard Pharmaceuticals, Inc.
Excaliard Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Excaliard Pharmaceuticals, Inc. manufactures, develops therapeutics for the treatment of scarring and fibrotic disorders. The company was founded by John Gordon Foulkes and Nicholas M. Dean in 2006 and is headquartered in New York, NY. | Pharmaceuticals: Major | Director/Board Member | |
Glaxo, Inc. | Chief Tech/Sci/R&D Officer | ||
Sandoz Pharmaceuticals Corp. | Corporate Officer/Principal | ||
Embic Corp.
Embic Corp. Information Technology ServicesTechnology Services Medical Care Corp. specializes in developing technologies for the precise measurement and monitoring of cognitive performance. The company was founded by William R. Shankle and Junko Hara in 1999 and is headquartered in Newport Beach, CA. | Information Technology Services | Director/Board Member | |
TREVI THERAPEUTICS, INC. | Biotechnology | Corporate Officer/Principal | |
BEYOND AIR, INC. | Medical Specialties | Director/Board Member | |
Beyond Air Ltd.
Beyond Air Ltd. BiotechnologyHealth Technology Beyond Air, Ltd. is a clinical-stage medical device and biopharmaceutical company engaging in the development of nitric oxide generator and delivery system that uses nitric oxide generated from ambient air and delivers precise amounts of nitric oxide to the lungs for the potential treatment of respiratory and other diseases. The company was founded by Yossef Av-Gay, Amir Avniel, and David Greenberg in May 2011 and is headquartered in Rehovot, Israel. | Biotechnology | Director/Board Member | |
Vivelix Pharmaceuticals, Ltd.
Vivelix Pharmaceuticals, Ltd. Pharmaceuticals: MajorHealth Technology Vivelix Pharmaceuticals, Ltd. manufactures and sells pharmaceutical products. The private company is based in Hamilton, BM. and has subsidiaries in the United States. The Bermudian company was founded by William P. Forbes. | Pharmaceuticals: Major | Chief Executive Officer | |
Lipidio Pharmaceuticals, Inc.
Lipidio Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Lipidio Pharmaceuticals, Inc. develops and manufactures medicines. It focuses on developing drugs to treat diseases associated with excess body fat and its lead program, GDD3898, is being investigated for the treatment of nonalcoholic steatohepatitis (NASH) and Prader Willi syndrome (PWS), an orphan disease, and anti-psychotic drug induced weight gain (AIWG). The company was founded by Jay Edward Birnbaum and is headquartered San Diego, CA. | Pharmaceuticals: Major | Founder | |
Thirona Bio, Inc.
Thirona Bio, Inc. Pharmaceuticals: MajorHealth Technology Thirona Bio, Inc. is an American biopharmaceutical company that focuses on developing drugs for fibrotic diseases. Thirona Bio is based in an undisclosed location. The private company's target indications include scleroderma, keloid scars, and certain cancers where there are no effective therapies. The company's unique approach uses a potent, topically applied drug to inhibit TGF-? "locally," minimizing the potential risk of systemic toxicity. The company was founded by John Gordon Foulkes, Jay Edward Birnbaum, K. George Mooney, and David A. Bullough, with John Gordon Foulkes serving as the CEO since incorporation. | Pharmaceuticals: Major | Founder |
Estadísticas
Internacional
Estados Unidos | 28 |
Suiza | 2 |
Canadá | 2 |
Israel | 2 |
Bermudas | 2 |
Sectorial
Health Technology | 20 |
Consumer Services | 6 |
Finance | 4 |
Process Industries | 2 |
Technology Services | 2 |
Operativa
Corporate Officer/Principal | 15 |
Director/Board Member | 10 |
Founder | 7 |
Chief Tech/Sci/R&D Officer | 5 |
Undergraduate Degree | 3 |
Las relaciones más conectadas
Insiders | |
---|---|
Jay Birnbaum | 13 |
William Forbes | 11 |
Mark T. Taylor | 9 |
Seth M. Birnbaum | 2 |
Hendrik Arend Kroon | 1 |
Feng-Yu Lee | 1 |
- Bolsa de valores
- Insiders
- Robert Orr
- Conexiones Empresas